XBI
State Street SPDR S&P Biotech ETF
3월 13일 4:00 PM ET (한국 3/14 05:00)
$121.83
-0.79 ▼ -0.64%
🌙 3월 13일 7:59 PM ET (한국 3/14 08:59)
$121.87
+0.04 ▲ +0.03%
| Index | - | P/E | - | EPS (ttm) | - | Insider Own | - | Shs Outstand | - | Perf Week | -1.75% |
| Market Cap | - | Forward P/E | - | EPS next Y | - | Insider Trans | - | Shs Float | - | Perf Month | -2.26% |
| Enterprise Value | - | PEG | - | EPS next Q | - | Inst Own | - | Short Float | - | Perf Quarter | -0.18% |
| Income | - | P/S | - | EPS this Y | - | Inst Trans | - | Short Ratio | 8.28 | Perf Half Y | 27.3% |
| Sales | - | P/B | - | EPS next 5Y | - | ROA | - | Short Interest | 76.62M | Perf YTD | -0.08% |
| Book/sh | - | P/C | - | EPS past 3/5Y | - | ROE | - | 52W High | -7.77% ($132.09) | Perf Year | 41.71% |
| Cash/sh | - | P/FCF | - | Sales past 3/5Y | - | ROIC | - | 52W Low | 82.76% ($66.66) | Perf 3Y | 56.47% |
| Dividend Est. | $0.45 (0.37%) | EV/EBITDA | - | EPS Y/Y TTM | - | Gross Margin | - | Volatility(W/M) | 2.53% 2.47% | Perf 5Y | -16.85% |
| Dividend TTM | 0.45 | EV/Sales | - | Sales Y/Y TTM | - | Oper. Margin | - | ATR (14) | 3.39 | Perf 10Y | 137.44% |
| Dividend Ex-Date | 2025/12/22 | Quick Ratio | - | EPS Q/Q | - | Profit Margin | - | RSI (14) | 41.88 | Recom | - |
| Dividend Gr. 3/5Y | - 9.6% | Current Ratio | - | Sales Q/Q | - | SMA20 | -3.07% ($125.69) | Beta | 0.92 | Target Price | - |
| Payout | - | Debt/Eq | - | Earnings | - | SMA50 | -2.85% ($125.4) | Rel Volume | 1.12 | Prev Close | $122.62 |
| Employees | - | LT Debt/Eq | - | EPS/Sales Surpr. | - | SMA200 | 15.19% ($105.76) | Avg Volume(3M) | 9.26M | Price | $121.83 |
| IPO | 2006/2/6 | Option/Short | Yes/Yes | Trades | 52138 | Volume | 10,405,315 | Change | -0.64% |
뉴스 로딩 중...